216 related articles for article (PubMed ID: 35042950)
1. The E3 ubiquitin ligase SOCS-7 reverses immunosuppression via Shc1 signaling in hepatocellular carcinoma.
Huang P; Zhao Z; Chen Y; Yang B; Xia J
Lab Invest; 2022 Jun; 102(6):613-620. PubMed ID: 35042950
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
[TBL] [Abstract][Full Text] [Related]
3. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
[TBL] [Abstract][Full Text] [Related]
4. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
5. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
[TBL] [Abstract][Full Text] [Related]
6. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
7. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
8. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
[TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
[TBL] [Abstract][Full Text] [Related]
10. Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3.
Williams JJ; Palmer TM
Biochem Soc Trans; 2012 Feb; 40(1):215-8. PubMed ID: 22260693
[TBL] [Abstract][Full Text] [Related]
11. SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma.
Yang SF; Yeh YT; Wang SN; Hung SC; Chen WT; Huang CH; Chai CY
Pathology; 2008 Oct; 40(6):558-63. PubMed ID: 18752121
[TBL] [Abstract][Full Text] [Related]
12. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
[TBL] [Abstract][Full Text] [Related]
13. p66Shc promotes HCC progression in the tumor microenvironment via STAT3 signaling.
Huang P; Feng X; Zhao Z; Yang B; Fang T; Guo M; Xia J
Exp Cell Res; 2019 Oct; 383(2):111550. PubMed ID: 31398350
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
15. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
[TBL] [Abstract][Full Text] [Related]
16. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
[TBL] [Abstract][Full Text] [Related]
17. The many faces of the SOCS box.
Piessevaux J; Lavens D; Peelman F; Tavernier J
Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
[TBL] [Abstract][Full Text] [Related]
18. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
[No Abstract] [Full Text] [Related]
19. E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis.
Guo Y; Li R; Tan Z; Shi J; Fu Y; Song Y; Zhu M; Zhang L; Huang J
Mol Immunol; 2020 May; 121():195-203. PubMed ID: 32298923
[TBL] [Abstract][Full Text] [Related]
20. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
